Related Experiment Video
Updated: Jul 15, 2026

09:54
Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
[Transfusion-related acute lung injury]
A Cottereau1, A Masseau, C Guitton
1Service de Médecine Interne, CHU Hôtel-Dieu, 9, quai Moncousu, 44093 Nantes 01 cedex, France.
Summary
Transfusion-related acute lung injury (TRALI) was previously underestimated. New data clarify its mechanisms and frequency, improving patient risk assessment and blood component safety.
Area of Science:
- Hematology
- Pulmonology
- Critical Care Medicine
Background:
- Transfusion-related acute lung injury (TRALI) is an interstitial lung injury occurring within 6 hours of blood transfusion.
- Diagnosis requires excluding other causes of lung edema, focusing on arterial desaturation without cardiac failure.
- Mechanisms include immune conflicts and neutrophil activation by transfusion components.
Purpose of the Study:
- To address the underestimation of TRALI frequency due to lack of definition and understanding.
- To present recent clinical and biological data enhancing TRALI knowledge.
- To improve the understanding of TRALI mechanisms and identify at-risk factors.
Main Methods:
- Review of clinical and biological data related to TRALI.
- Analysis of diagnostic criteria, including timing and exclusion of other conditions.
- Discussion of identified etiological mechanisms.
Main Results:
- TRALI diagnosis is based on acute onset of lung edema post-transfusion, excluding other causes.
- Key mechanisms involve immune reactions and neutrophil activation.
- Predisposing factors include pre-existing conditions like lung capillary leukostasis.
Conclusions:
- Improved understanding of TRALI enhances knowledge of blood transfusion's role in complex lung edema.
- This knowledge facilitates better identification of at-risk patients and blood components.
- Further research can refine diagnostic criteria and preventative strategies.
Related Concept Videos
Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-I
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Pneumothorax-I
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-IV
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
Acute Respiratory Failure-III
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...

